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Abstract
The introduction and removal of the 2,4-dimethoxybenzyl 
(DMB) moiety was studied in order to use it as a protecting 
group in the synthesis of diverse drug candidates containing 
the 1,3-diazaoxindole scaffold. The debenzylation of 
C(5)-unsubstituted and C(5)-isopropylidene-substituted 
1,3-diazaoxindoles was investigated under various conditions. 
The DMB group could only be removed from the latter 
derivative using triflic acid. This observation can most likely 
be explained with electronic effects. In order to get a deeper 
insight into the reaction mechanism, quantum chemical 
calculations have been performed.
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1 Introduction
The interest in 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-
one derivatives (1,3-diazaoxindoles) increased in the last few 
years due to the biological relevance of compound families 1 
and 2 (Scheme 1) [1-5].
Scheme 1 Drug candidates with 1,3-diazaoxindole skeleton
In our earlier study, the easily available 2-(4-chloropyrimidin-
5-yl)acetate derivatives 3a–d were reacted with ammonia to 
afford the corresponding 2-(4-aminopyrimidin-5-yl)acetamides 
4a–d, which were finally cyclized to N-unsubstituted 
1,3-diazaoxindoles 5a–d (Scheme 2) [6].
Vaid et al. treated compound 6 with ammonia (3.7 equiv., 
1.0 M propan-2-ol solution) at 90°C followed by the 
cyclization of non-isolated intermediate 7a to give 4-chloro-
1,3-diazaoxindole 8a with 60% yield (Scheme 3) [7]. The 
complex workup procedure involved 3 steps: a) removal of the 
inorganic salts by filtration, b) concentration of the reaction 
mixture, c) dissolution of the residue in ethyl acetate followed 
by activated charcoal treatment, which was used to remove the 
majority of by-product 9, d) aqueous extraction of the ethyl 
acetate layer and concentration of the solution to obtain the 
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crude product, and finally e) crystallization of the crude product 
from dichloromethane and heptane to obtain 8a. 
According to the literature, 2,4-dimethoxybenzylamine reacts 
under mild conditions with methyl (4,6-dichloropyrimidin-
5-yl)acetate (6) and or its analogues (such as 10, Scheme 4) 
and the products can be cyclized to the corresponding 
1,3-diazaoxindoles [7, 8]. Vaid et al. treated compound 6 
with 2,4-dimethoxybenzylamine and α-methylbenzylamine 
in N,N-dimethylformamide (DMF) in the presence of N,N-
diisopropylethylamine (DIPEA) followed by the cyclization 
of non-isolated intermediates 7b,c to give 4-chloro-1,3-
diazaoxindoles 8b,c with 78–88% yields (Scheme 3) [7]. It is 
known that the 2,4-dimethoxybenzyl (DMB) group can be easily 
eliminated from amides by oxidation or under acidic conditions 
[9, 10]. Several attempts were made using this approach for the 
synthesis of N(7)-unsubstituted 4-chloro-1,3-diazaoxindole 8a 
by treating 8b,c with sulfonic acids such as methanesulfonic 
acid, p-TsOH and triflic acid. Nevertheless, the formation of the 
desired product 8a was not observed [7, 9, 10]. 
2,4-Dimethoxybenzylamine hydrochloride in presence 
of DIPEA was successfully used for the substitution of the 
halogen atom from chloro-ester compound 10, yielding DMB 
amino ester derivative 11 in 76% yield [8]. Further the complete 
DMB group removal with p-TsOH under acidic conditions and 
the subsequent cyclization step provided only the unprotected 
2-substituted 4-chloro-1,3-diazaoxindole 12 with 64% yield in 
one-pot manner.
The selectivity of the alkylation reactions of N(7)-
unprotected 1,3-diazaoxindoles has been recently described by 
us [11]. Herein the introduction and removal of DMB moiety on 
N(7) atom as an alternative approach to ensure C(5) selectivity 
is presented. As shown above, deprotection of DMB-amides 
usually occurs easily under acidic conditions [9]. However, 
the usefulness of DMB-protection/deprotection only in case of 
2- and 4-substituted diazaoxindoles was already investigated. 
Our aim was to extend this approach to the unsubstituted 
analogue 5a and to provide a suitable mechanism for the 
deprotection step.
2 Results and Discussion
The synthesis of the N(7)-substituted target compound was 
carried out starting from 2-(4-chloropyrimidin-5-yl)acetate 
(3a), which was treated with 2,4-dimethoxybenzylamine 
hydrochloride (13) and DIPEA in DMF under argon atmosphere 
at 110°C (Scheme 5). In the cyclization step of the DMB-amino 
substituted pyrimidine 14 thus obtained, sodium ethoxide 
(NaOEt) was used in dry ethyl acetate (EtOAc) to give DMB-
protected diazaoxindole 15.
Scheme 2 Synthesis of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones (1,3-diazaoxindoles)
Scheme 3 Synthesis of N(7)-substituted 4-chloro-1,3-diazaoxindoles (8b,c) and attempts for the removal of the protecting groups to give 8a
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Further debenzylation of 15 performed with p-TsOH, 
5 M sulfuric acid, acetic acid, trifluoroacetic acid (TFA), 
methanesulfonic acid and triflic acid in the presence of anisole 
failed, the desired unprotected 5a was not formed (Scheme 6). 
These results were in accordance with earlier finds concerning 
the stability of N-benzylated 8b,c under acidic conditions [7]. 
The oxidative removing of DMB with cerium ammonium nitrate 
(CAN, 3 equiv.) in acetonitrile-water or with 2,3-dichloro-5,6-
dicyanobenzoquinone (DDQ, 1.5 equiv.) in DCM [9] was also 
useless for the deprotection of 15.
Condensation of N(7)-protected 1,3-diazaoxindole 15 with 
acetone in acetic acid afforded N(7)-substituted 5- isopropylidene-
1,3-diazaoxindole 16 in 98% yield (Scheme 6) [11]. DMB 
deprotection of 16 occurred using a mixture of trifluoroacetic 
acid and triflic acid in the presence of the leaving group 
entrapping anisole [12-13] yielding (25%) 5-isopropylidene-
1,3-diazaoxindole (17). The difference in reactivity found for 
deprotection of 15 and 16 enforced us to investigate the reaction 
mechanism using quantum chemical calculations.
All calculations were carried out with the Gaussian09 
software [14]. The calculations were performed on ωB97XD/6-
311++G(2df,2pd)//ωB97XD/6-31+G(d,p) level of theory in 
the presence of the IEF-PCM solvation model with UFF radii 
[15, 16]. TFA was selected as the solvent.
The reaction mechanism was also investigated with the 
variation of the dielectric constant, and it was found that there 
was no significant difference in the outcome of the calculations. 
For comparison, the ratio of the reaction rates was calculated 
based on the Arrhenius-equation, where the pre-exponential 
factor was considered the same for 15 and 16 since they are 
very similar compounds. (Fig. 1)
Fig. 1 Calculation of the ratio of reaction rates
It was assumed that only protonated 15 and 16 could be 
transformed into free amides, since strong acidic reaction 
conditions were the prerequisite of DMB deprotection. Because 
pKa of triflic acid is much lower than that of TFA, the formation 
Scheme 4 Synthesis of 2-substituted 4-chloro-1,3-diazaoxindole 12
Scheme 5 Synthesis of N(7)-protected 1,3-diazaoxindole (15)
Scheme 6 Attempts for the debenzylation of compounds 15 and 16
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energies for protonated 15 and 16 triflates were calculated. 
Detailed investigation of protonation, tautomerization and 
transition-state energies involving all proton-acceptor sites and 
tautomers revealed that DMB deprotection could proceed only 
from double protonated molecules. Two energetically close 
reaction mechanisms were formulated: (I.) the transition state 
occurs from the double protonated pyrimidine ring; or (II.) one 
of the two protons is migrating to the oxo group enhancing 
the debenzylation by favouring the oxo-enol tautomerization 
in the transition state (Scheme 7).
It is important to note that triple-protonation of the 
molecules is energetically less favourable. Furthermore, 
transition states involving nitrogen protonated amide tautomer 
or protonated DMB group were energetically ruled out. Since 
calculations demonstrated that the second protonation of the 
already protonated pyrimidine ring is energetically favoured, 
it was assumed that the most feasibly mechanism is depicted 
in Scheme 7, path I.
It was also found a slight energetic difference (1.20 kcal/mol) 
for protonation but a more significant difference in transition 
state energies (3.64 kcal/mol) between 15 and 16 (Fig. 2), 
explaining why 16 is deprotected about 200 times faster than 15.
Comparing in transition states the Mulliken charge 
distribution of the amide nitrogen atom and the methylene unit 
of DMB group (Fig. 3) it was found that in the double protonated 
15 the electrostatic force between the amide nitrogen atom and 
the DMB methylene group is much stronger than in the similar 
transition state generated from compound 16. A larger partial 
charge difference causes a greater cohesive force between the 
amide nitrogen and the leaving group, reducing the reactivity 
Scheme 7 The two most preferred mechanisms
Fig. 2 Gibbs Free Energy diagram of deprotection of compounds 15 and 16
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of 15 compared to 16.
3 Conclusion
In order to explain the significant difference between the 
reactivity of compounds 15 and 16 in terms of removal of 
the DMB protecting group, the investigation of the reaction 
mechanism of these two 5,7-dihydro-6H-pyrrolo[2,3-d]
pyrimidin-6-one derivatives has been performed. Due to the 
multiple proton-acceptor sites of both 15 and 16, the exact 
mechanism of the deprotection reaction remains uncertain. It 
was found a slight energetic difference in protonation but a 
significant difference between the transition states of the most 
favoured mechanism. This result was explained taking into 
account the charge delocalizing effect of the isopropylidene 
group, enhancing the protonation of 16 compared to 15 and 
improving the formation of the unprotected product from 16.
4 Experimental section
Melting points were determined on an OptiMelt Automated 
Melting Point System by Stanford Research Systems. IR spectra 
were obtained on a Bruker IFS-113v FT spectrometer. 1H NMR 
and 13C NMR spectra were recorded on a Bruker Avance III 
(400 and 100 MHz for 1H and 13C NMR spectra, respectively). 
Chemical shifts (δ) and coupling constants (J) are given in parts 
per million and in Hertz. The ESI+ mass spectra were recorded 
on a Thermo LTQ XL mass spectrometer coupled with an 
AcquityTM UPLC. The reactions were followed by analytical 
thin layer chromatography on silica gel 60 F254. All unspecified 
reagents were purchased from commercial sources.
Ethyl (4-{[(2,4-dimethoxyphenyl)methyl]amino} 
pyrimidin-5-yl)acetate (14). To a stirred solution of ethyl 
2-(4-chloropyrimidin-5-yl)acetate (3a, 2.10 g, 10.5 mmol) in 
DMF (25 mL) 2,4-dimethoxybenzylamine hydrochloride (13, 
2.24 g, 11 mmol) and DIPEA (3.67 mL, 2.71 g, 21 mmol) 
were added at room temperature (rt) under argon. The reaction 
mixture was stirred at 110°C for 3 hours. After the reaction was 
complete and cooled to rt, water (150 mL) was added to the 
mixture and stirred for 30 min. The crystalline precipitate was 
filtered off, washed with water (2×30 mL) and dried to give 
14 pale brown crystals (2.08 g, 6.0 mmol, 60%). An analytical 
sample was obtained by recrystallization from toluene to give 
colourless crystals. Mp. 123-125°C (toluene). IR (KBr): ν 
1717, 1598, 1588 cm-1. 1H NMR (400 MHz, CDCl3): δ 8.56 (s, 
1H), 8.00 (s, 1H), 7.26-7.22 (t, J=8.2 Hz, 1H), 6.48 (d, J=2.3 
Hz, 1H), 6.44-6.42 (dd, J=8.2, 2.3 Hz, 1H), 6.00 (s, 1H), 4.64 
(d, J=5.5 Hz, 2H), 4.13-4.08 (q, J=7.1 Hz, 2H), 3.86 (s, 3H), 
3.80 (s, 3H), 3.36 (s, 2H), 1.21-1.18 (t, J=7.2 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 170.3, 160.6, 160.5, 158.7, 157.8, 
154.7, 130.2, 119.0, 110.9, 103.8, 98.6, 61.5, 55.4, 55.3, 40.3, 
35.7, 14.0. MS: 332.23 (M+H)+. 
7-(2,4-Dimethoxybenzyl)-5,7-dihydro-6H-pyrrolo[2,3-d]
pyrimidin-6-one (15). To a vigorously stirred suspension 
of sodium ethoxide (3.35 g, 47.3 mmol) and ethyl acetate 
(60 mL), a solution of ethyl (4-{[(2,4-dimethoxyphenyl)
methyl]amino}pyrimidin-5-yl)acetate (14, 7.12 g, 21.5 mmol) 
in ethyl acetate (210 mL) was added at 0°C. The cooling bath 
was removed and stirring was continued at 20°C for 10 min. 
After the reaction was complete, it was cooled to 10°C and 
acetic acid (5.32 mL, 5.58 g, 92.9 mmol) was added to the 
mixture. Stirring was continued for 30 min, and then the 
volatile components were evaporated at 40°C. The residue was 
dissolved in distilled water (180 mL) and stirred for 2 hours. 
The crystalline precipitate was filtered off, washed with water 
(2×30 mL) and dried to give 15 as pale brown crystals (5.42 
g, 19.0 mmol, 88%). An analytical sample was obtained by 
recrystallization from EtOAc to give colourless crystals. Mp. 
122.5-123.5°C (EtOAc). IR (KBr): ν 1730, 1470 cm-1. 1H NMR 
(400 MHz, CDCl3): δ 8.79 (s, 1H), 8.32 (s, 1H), 7.12-7.10 (d, 
J=8.3 Hz, 1H), 6.44 (d, J=2.4 Hz, 1H), 6.41-6.39 (dd, J=8.3, 
2.4 Hz, 1H), 4.95 (s, 2H), 3.80 (s, 3H), 3.77 (s, 3H), 3.36 (s, 
2H), 3.60 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 173.5, 164.9, 
160.6, 158.3, 157.8, 148.7, 129.6, 116.7, 115.7, 103.9, 98.6, 




pyrimidin-6-one (15, 0.45 g, 1.6 mmol) was stirred in acetone 
(6.80 mL, 5.37 g, 90.9 mmol) and acetic acid (2.40 mL, 2.52 g, 
41.9 mmol) at 60°C for 7 hours under argon atmosphere. The 
solvent was removed in vacuo, water (40 mL) and ethanol 
(2 mL) were added to the residue, and it was stirred for 1 hour. 
The crystalline precipitate was filtered off, washed with 
water (5×10 mL) and dried in a desiccator over phosphorous 
pentoxide in vacuo to give 16 as pale brown crystals (0.51 g, 
1.57 mmol, 98%). An analytical sample was obtained by 
recrystallization from EtOAc to give colourless crystals. Mp. 
164-165.5°C (EtOAc). IR (KBr): ν 1712, 1480 cm-1. 1H NMR 
(400 MHz, CDCl3): δ 8.73 (s, 1H), 8.59 (s, 1H), 6.99-6.97 (d, 
J=8.4 Hz, 1H), 6.44 (d, J=2.4 Hz, 1H), 6.39-6.36 (dd, J=8.4, 
2.4 Hz, 1H), 5.01 (s, 2H), 3.81 (s, 3H), 3.76 (s, 3H), 2.64 (s, 
3H), 2.41 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 166.6, 160.4, 
160.3, 160.158.1, 156.4, 146.5, 128.7, 118.9, 116.4, 116.4, 
104.0, 98.6, 55.4, 55.3, 37.3, 25.7, 23.3. MS: 326.22 (M+H)+.
Fig. 3 Mulliken charges of the amide nitrogen and the DMB methylene




(16, 75 mg, 0.23 mmol) was stirred in a mixture of triflic acid 
(1.00 mL, 1.70 mg, 11.3 mmol) and trifluoroacetic acid (1 mL, 
1.49 g, 13.00 mmoL) in the presence of anisole (1.00 mL, 
96.00 mg, 9.12 mmol) at 25°C for overnight, then 1 h at 
reflux temperature. The volatile compounds were removed 
in vacuo and water (5 mL) was added. It was extracted with 
DCM (3×5 mL). The combined organic layer was washed with 
cc. aqueous NaHCO3 solution (3×10 mL) and brine (20 mL), 
then dried and evaporated to give the crude 17 product. It 
was purified by column chromatography using EtOAc as the 
eluent. The product 17 (31 mg, 25%) was obtained as white 
crystals. Mp. 200°C decomp. (DMF). IR (KBr): ν 1718 cm-1. 
1H NMR (400 MHz, DMSO-d6): δ 11.52 (s, 1H), 8.66 (s, 1H), 
8.63 (s, 1H), 2.53 (s, 3H), 2.36 (s, 3H). 13C NMR (100 MHz, 
DMSO-d6): δ 167.6, 160.4 (2 signals: 160.40, 160.36), 156.1, 
147.3, 119.1, 116.5, 25.7, 22.7. MS: 175.98 (M+H)+.
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